Efficacy of Personal Pharmacogenomic Testing as an Educational Tool in the Pharmacy Curriculum
NCT ID: NCT04889014
Last Updated: 2021-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
233 participants
INTERVENTIONAL
2016-03-03
2021-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial of Preemptive Pharmacogenetics in Underserved Patients
NCT05141019
Pharmacogenetic Testing in Primary Care
NCT01600846
Preemptive Pharmacogenomics Testing Among Geriatric Patients
NCT05091879
Pilot of Preemptive Pharmacogenetics in Medically Underserved Patients
NCT04630093
Utility of Pharmacogenomic Testing in Patients With Gastrointestinal Disorders
NCT05572593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Personal genomic educational testing (PGET)
PGET group participants received their own pharmacogenomic testing results prior to the course modules covering material tested in the knowledge assessment
Personal genomic educational testing (PGET)
PGET consisted of a panel of pharmacogenomic variants
No personal genomic educational testing (NPGET)
No PGET (NPGET) group participants did not receive their own pharmacogenomic testing results until after study completion.
No personal genomic educational testing (NPGET)
Lack of pharmacogenomic testing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Personal genomic educational testing (PGET)
PGET consisted of a panel of pharmacogenomic variants
No personal genomic educational testing (NPGET)
Lack of pharmacogenomic testing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Enrolled in 3rd year Doctor of Pharmacy course
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arizona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1602413309
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.